Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Cigna Stock Dives
Cigna Stock Dives After Earnings. Here’s What Went Wrong.
Cigna Group stock was falling sharply after the health insurer missed quarterly earnings estimates and issued light guidance amid higher medical costs. Cigna stock dropped 9% to $276 in premarket trading Thursday.
Why Cigna Stock Is Plummeting Today
Shares of Cigna ( CI -8.00%) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m. ET but had lost as much as 11.3% earlier in the day. The leg down comes as the S&P 500 gained 0.2% and the Nasdaq Composite lost 0.2%.
Why Cigna (CI) Stock Is Down Today
What Happened? Shares of health insurance company Cigna (NYSE:CI) fell 8.5% in the afternoon session after the company reported underwhelming fourth quarter earnings. EPS in the quarter missed and its full-year EPS guidance missed significantly.
Cigna tumbles
Cigna quarterly profit hit by higher medical costs, shares tumble
Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, as high-cost claims in employer-sponsored plans drove up expenses in its backup insurance product.
Cigna tumbles after medical costs hit quarterly profit
Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical costs, a trend that’s concerned investors in the sector for months.
Cigna drops as rising medical costs drive Q4 earnings miss
Cigna (CI) stock falls as the managed care company's Q4 2024 earnings miss the consensus due to an unexpected rise in medical costs. Read more here.
7h
Cigna price target lowered to $360 from $415 at Raymond James
Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares.
2d
Cigna taking steps to lower out-of-pocket cost of prescription drugs
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
Modern Healthcare
1d
Cigna to spend $150M to improve prior auth, patient advocacy: CEO
Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...
8h
Cigna price target lowered to $375 from $400 at Oppenheimer
Oppenheimer lowered the firm’s price target on Cigna (CI) to $375 from $400 and keeps an Outperform rating on the shares. The firm notes ...
STAT
1d
Cigna’s lower earnings reveal how sick American workers are
Cigna blamed lower-than-expected fourth-quarter returns on its stop-loss insurance business that insures employers from ...
2d
Cigna Plans to Limit Out-Of-Pocket Drug Costs for US Patients
Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...
12h
Connecticut-based Cigna announces plan to reduce prescription-drug costs
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.
1d
on MSN
Cigna projects 2025 EPS of at least $29.50 amid biosimilar growth and strategic investments
Q4 2024 Management View CEO David Cordani highlighted Cigna's full-year revenue growth of $247 billion, a 27% increase, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Wall Street
S&P 500 Index
Q4
Earnings per share
Trade
Feedback